Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
- PMID: 1969518
- DOI: 10.1016/0140-6736(90)90878-9
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
Abstract
The associations of diastolic blood pressure (DBP) with stroke and with coronary heart disease (CHD) were investigated in nine major prospective observational studies: total 420,000 individuals, 843 strokes, and 4856 CHD events, 6-25 (mean 10) years of follow-up. The combined results demonstrate positive, continuous, and apparently independent associations, with no significant heterogeneity of effect among different studies. Within the range of DBP studied (about 70-110 mm Hg), there was no evidence of any "threshold" below which lower levels of DBP were not associated with lower risks of stroke and of CHD. Previous analyses have described the uncorrected associations of DBP measured just at "baseline" with subsequent disease rates. But, because of the diluting effects of random fluctuations in DBP, these substantially underestimate the true associations of the usual DBP (ie, an individual's long-term average DBP) with disease. After correction for this "regression dilution" bias, prolonged differences in usual DBP of 5, 7.5, and 10 mm Hg were respectively associated with at least 34%, 46%, and 56% less stroke and at least 21%, 29%, and 37% less CHD. These associations are about 60% greater than in previous uncorrected analyses. (This regression dilution bias is quite general, so analogous corrections to the relations of cholesterol to CHD or of various other risk factors to CHD or to other diseases would likewise increase their estimated strengths.) The DBP results suggest that for the large majority of individuals, whether conventionally "hypertensive" or "normotensive", a lower blood pressure should eventually confer a lower risk of vascular disease.
Comment in
-
Meta-analysis of hypertension treatment trials.Lancet. 1990 May 5;335(8697):1092-4. Lancet. 1990. PMID: 1970385 No abstract available.
-
Regression dilution bias.Lancet. 1990 May 19;335(8699):1230-1. Lancet. 1990. PMID: 1971081 No abstract available.
-
Correction for regression dilution bias.Lancet. 1990 Jun 23;335(8704):1534. doi: 10.1016/0140-6736(90)93081-y. Lancet. 1990. PMID: 1972468 No abstract available.
Similar articles
-
Implications of small reductions in diastolic blood pressure for primary prevention.Arch Intern Med. 1995 Apr 10;155(7):701-9. Arch Intern Med. 1995. PMID: 7695458
-
Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease.Hypertension. 1989 May;13(5 Suppl):I45-50. doi: 10.1161/01.hyp.13.5_suppl.i45. Hypertension. 1989. PMID: 2490828 Review.
-
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.Lancet. 1990 Apr 7;335(8693):827-38. doi: 10.1016/0140-6736(90)90944-z. Lancet. 1990. PMID: 1969567 Review.
-
The effects of antihypertensive drug treatment on the incidence of stroke and of coronary heart disease.Clin Exp Hypertens A. 1989;11(5-6):807-23. doi: 10.3109/10641968909035375. Clin Exp Hypertens A. 1989. PMID: 2676257 Review.
-
Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease?J Hum Hypertens. 1988 Jun;2(1):7-10. J Hum Hypertens. 1988. PMID: 3236316
Cited by
-
Age-dependent sex differences in cardiometabolic risk factors.Nat Cardiovasc Res. 2022 Sep;1(9):844-854. doi: 10.1038/s44161-022-00131-8. Epub 2022 Sep 12. Nat Cardiovasc Res. 2022. PMID: 39196077 Free PMC article.
-
Physical Activity and Cardiac Morphologic Adaptations.Rev Cardiovasc Med. 2023 May 11;24(5):142. doi: 10.31083/j.rcm2405142. eCollection 2023 May. Rev Cardiovasc Med. 2023. PMID: 39076738 Free PMC article. Review.
-
Waist-to-height ratio and body fat percentage as risk factors for ischemic cardiovascular disease: a prospective cohort study from UK Biobank.Am J Clin Nutr. 2024 Jun;119(6):1386-1396. doi: 10.1016/j.ajcnut.2024.03.018. Epub 2024 May 9. Am J Clin Nutr. 2024. PMID: 38839194 Free PMC article.
-
Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee.J Pharmacol Toxicol Methods. 2024 May-Jun;127:107511. doi: 10.1016/j.vascn.2024.107511. Epub 2024 May 6. J Pharmacol Toxicol Methods. 2024. PMID: 38710237 Review.
-
Fasting Triglycerides in the Upper Normal Range Are Independently Associated with an Increased Risk of Diabetes Mortality in a Large Representative US Population.J Cardiovasc Dev Dis. 2024 Apr 21;11(4):128. doi: 10.3390/jcdd11040128. J Cardiovasc Dev Dis. 2024. PMID: 38667746 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical